proAVP hormone

08/24/2021 - "Risk assessment of sepsis through measurement of proAVP (copeptin): a secondary analysis of the TRIAGE study."
10/01/2015 - "The CT-proAVP measured within 24 h of sepsis onset failed to predict vasopressor need. "
10/01/2015 - "The CT-proAVP was measured at three time points within the first week after sepsis onset. "
10/01/2015 - "Our study further confirms previous data on the ability of the CT-proAVP to predict patient severity in severe sepsis and septic shock."
10/01/2015 - "More importantly, CT-proAVP plasma levels in patients with a sustained need of vasopressors did not differ from vasopressor-free patients at days 1 and 2. The CT-proAVP was more elevated in septic shock as compared with severe sepsis or nonseptic patients. "

02/01/2006 - "Thus, strategies for targeting proAVP should be examined for their effectiveness in diagnosing and treating breast cancer."
04/08/2010 - "Thus, proAVP appears to be an attractive target for the detection of invasive breast cancer and DCIS, and these results suggest that MAG1 may be a beneficial tool for use in the development of such strategies."
02/01/2006 - "However, little is known about the regulation of the AVP protein precursor (proAVP) or AVP-mediated signaling in breast cancer and this study was undertaken to address some of the basic issues. "
02/01/2006 - "The cultured cell lines examined (Mcf7, Skbr3, BT474, ZR75, Mcf10a) and human breast cancer tissue extract were found to express proAVP mRNA. "
04/08/2010 - "The provasopressin protein (proAVP) is expressed by invasive breast cancer and non-invasive breast cancer, or ductal carcinoma in situ (DCIS). "

01/01/2019 - "Using data from the multicenter, observational Diast-CHF (Diagnostic Trial on Prevalence and Clinical Course of Diastolic Dysfunction and Heart Failure) study, this post-hoc analysis aimed at assessing the association between serum concentrations of C-terminal pro-arginine vasopressin (CT-proAVP) and anxiety in patients with cardiovascular risk factors. "

10/01/2015 - "CT-proAVP IS NOT A GOOD PREDICTOR OF VASOPRESSOR NEED IN SEPTIC SHOCK."
10/01/2015 - "Our study further confirms previous data on the ability of the CT-proAVP to predict patient severity in severe sepsis and septic shock."
10/01/2015 - "More importantly, CT-proAVP plasma levels in patients with a sustained need of vasopressors did not differ from vasopressor-free patients at days 1 and 2. The CT-proAVP was more elevated in septic shock as compared with severe sepsis or nonseptic patients. "

01/01/2017 - "Receiver operator curve analysis showed that NT-proBNP values over 13,184 pg/mL predicted the use of at least 3 antihypertensive drugs in maximal doses in the therapy of hypertension, similar analyses performed for CT-proAVP showed much less specificity. "
01/01/2017 - "Therefore, the aim of this study was to assess plasma levels of N-terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) and a C-terminal portion of the precursor of vasopressin (CT-proAVP, copeptin), surrogate markers of volume overload in HD patients in relation to the number of antihypertensive drugs used in the hypertension treatment. "